News
-
-
PRESS RELEASE
Hardman & Co Q&A on ICG Enterprise Trust (ICGT): How a unique capital strategy drives long-term investor gains
Hardman & Co's Q&A on ICG Enterprise Trust highlights its unique capital strategy driving long-term gains. Analyst Mark Thomas delves into progressive dividends, compounding growth, and buybacks creating value for investors -
-
-
-
-
-
-
-
PRESS RELEASE
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven. Shield Therapeutics increasing physician awareness for ACCRUFeR® sales traction